US Patent Issued to DANA-FARBER CANCER INSTITUTE on Feb. 17 for "ERK5 degraders as therapeutics in cancer and inflammatory diseases" (Massachusetts, California Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,551,563, issued on Feb. 17, was assigned to DANA-FARBER CANCER INSTITUTE INC. (Boston).

"ERK5 degraders as therapeutics in cancer and inflammatory diseases" was invented by Nathanael S. Gray (Stanford, Calif.), Jinhua Wang (Winchester, Mass.), Fleur Marcia Ferguson (Boston), Jie Jiang (Brookline, Mass.) and Inchul You (Boston).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are bispecific compounds (degraders) that target ERK5 for degradation. Also disclosed are pharmaceutical compositions containing the degraders and methods of using the compounds to treat cancer and inflammatory diseases."

The patent was filed on Sept. 24, 2020, under Applica...